Publié il y a 21 mois
Join the Alpha-9 Talent Network
@ Alpha-9 Oncology
Vancouver, Colombie-Britannique
En bref
Alpha-9 Oncology is building a talent network for future openings in its radiopharmaceutical cancer drug work across Vancouver, Boston and San Francisco. Candidates can join the network to be considered as roles open; no current role is posted.
Résumé des exigences :
It invites candidates whose background may align with future roles at the company.
Source et dates
Site carrière / système de candidatures · greenhouse
- Date publiée par l’employeur
- 2025-02-11
- Première détection par notre source
- 2026-10-10
- Mise à jour du dossier source
- 2026-11-05
Ces dates décrivent le dossier source, pas une vérification en direct du recrutement. Consultez l’offre originale.
Détails du poste
| Domaine | Recherche et sciences |
| Milieu de travail | Bureau, Laboratoire |
Résumé et détails rédigés par l’IA à partir de l’offre; l’offre de l’employeur fait foi.
Alpha-9 Oncology
Profil d’entreprise sauvegardé
Renseignements historiques provenant d’un profil The Jobs API sauvegardé (champs LinkedIn/Crunchbase). Ils ne sont pas vérifiés en temps réel; les chiffres peuvent avoir changé. Les valeurs manquantes restent inconnues.
Description complète de l’entreprise
Alpha-9 Oncology is a clinical stage, radiopharmaceutical company developing differentiated and highly targeted radiopharmaceuticals with the potential to meaningfully improve the treatment of people living with cancer. Applying proprietary technologies and deep-foundational expertise, Alpha-9 is on the forefront of engineering bespoke radiopharmaceuticals that are optimized to selectively deliver radiation to tumor sites while minimizing off-target effects. Alpha-9 is advancing a robust pipeline of novel radiopharmaceuticals with a systematic approach to molecule design that offers broad potential for expansion into several validated oncology targets. Alpha-9 was founded by researchers from the University of British Columbia and BC Cancer, with the goal of improving the lives of patients affected by metastatic cancers.
- Abonnés LinkedIn
- 11 764
- Personnes associées sur LinkedIn
- 32
- Bureaux déclarés
- Boston, Massachusetts, US
- Vancouver, BC, CA
- Catégories d’activité
- Biopharma
- Biotechnology
- Clinical Trials
- Medical
- Product Research
- Autres noms enregistrés
- Alpha-9 Oncology
- Spécialités
- PET Imaging
- Radiotherapy
- Clinical Trials
- and Biotechnology
- Le profil indique une agence de recrutement
- Non
- Investissement total déclaré
- 259 017 545
La devise et la date d’observation ne sont pas fournies; ce n’est ni une valorisation actuelle ni une ronde de financement.
Alpha-9 Oncology is a clinical stage, radiopharmaceutical company developing differentiated and highly targeted radiopharmaceuticals with the potential to meaningfully improve the treatment of people living with cancer. Applying proprietary technologies and deep-foundational expertise, Alpha-9 is on the forefront of engineering bespoke radiopharmaceuticals that are optimized to selectively deliver radiation to…
| Champ | Valeur |
|---|---|
| Secteur | Biotechnology Research |
| Taille | 51-200 employees |
| Siège social | Boston, Massachusetts |
| Type d’organisation | Privately Held |
| Spécialités | PET ImagingRadiotherapyClinical Trialsand Biotechnology |
| Offres sur Jobsy | 1 |
| Voir la page |
Join the Alpha-9 Talent Network
At Alpha-9 Oncology, our mission is to advance next-generation radiopharmaceuticals that meaningfully improve outcomes for patients with cancer. We’re building a team of thoughtful, driven individuals who are motivated by impact and grounded in scientific excellence, collaboration, and urgency.
If you don’t see a current role that aligns with your background, we’d still love to connect. By joining our Talent Network, you’ll be considered for future opportunities as we continue to grow across Vancouver, Boston, and San Francisco.
We regularly review submissions and will reach out if there’s a strong match.
Company Summary
Alpha-9 Oncology is a clinical-stage biotechnology company pioneering radiopharmaceutical innovation for solid tumors. Our proprietary scaffolds, composed of optimized binders, linkers, chelators, and radioisotopes, enable targeted radiation delivery to cancer cells, minimizing harm to surrounding healthy tissue. Focusing on innovative targeting moieties, we develop molecules tailored for precise tumor targeting.
Our comprehensive platform integrates imaging and therapeutic studies to ensure effective radiation delivery and improved patient outcomes. With a robust pipeline entering clinical trials and strong support from leading healthcare investors, Alpha-9 is positioned for rapid growth and advancement in cancer therapy.
More about Alpha-9 Oncology
Alpha-9 Oncology is committed to fostering a diverse and inclusive workplace and is proud to be an Equal Opportunity Employer. We provide employment opportunities to all qualified applicants without regard to race, ethnicity, religion, age, sex, gender identity or expression, sexual orientation, disability, marital status, family status, national origin, or any other characteristic protected by applicable federal, provincial, or local laws where we operate.
We are dedicated to providing reasonable accommodations to qualified applicants and employees to ensure that everyone can perform their essential job functions in an inclusive environment. For inquiries regarding accommodations in the hiring process or for current employees, please contact a member from our Talent Acquisition team.
Journal
Visible seulement par vous. Conservé sur cet appareil, et dans votre compte une fois connecté.